Miklós Gyuranecz was awarded funding under the ADVANCED call of the National Research Excellence Program, administered by the National Research, Development and Innovation Office (NRDI Office). Out of 830 submitted proposals, 192 outstanding researchers received funding. The grant supports the development of the research group and the implementation of the basic research project titled "Development of Mycoplasma synoviae vaccine candidates".